Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “COVID-19”

Long-Term Outcomes After the Multisystem Inflammatory Syndrome in ChildrenActive Not Recruiting
NCT05287412N/AUpdated Mar 27, 2026
Sponsor: Carelon Research
Multisystem Inflammatory Syndrome in Children (MIS-C)
United States, Canada
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine FormulationsRecruiting
NCT06585241Phase 4Updated Mar 27, 2026
Sponsor: ModernaTX, Inc.
SARS-CoV-2
United States
Investigation of Physical Impairments in Young AdultsCompleted
NCT06561776N/AUpdated Mar 27, 2026
Sponsor: Izmir Democracy University
Adult Children
Turkey (Türkiye)
Understanding the Long-term Impact of COVID-19 in AdultsNot Yet Recruiting
NCT07498504N/AUpdated Mar 27, 2026
Sponsor: NYU Langone Health
Long COVID · Long Covid19
United States
Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy IndividualsCompleted
NCT04368728Phase 2, Phase 3Updated Mar 25, 2026
Sponsor: BioNTech SE
SARS-CoV-2 Infection · COVID-19
United States, Argentina, Brazil, Germany, South Africa +1 more
Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 InfectionRecruiting
NCT04367883N/AUpdated Mar 25, 2026
Sponsor: Consorci Sanitari de Terrassa
COVID19 · Influenza Vaccination · ACE Inhibitors · ARB
Spain
Trial of Imatinib for Hospitalized Adults With COVID-19Terminated
NCT04394416Phase 3Updated Mar 25, 2026
Sponsor: University of Maryland, Baltimore
COVID-19
United States
Blood Product SupplyCompleted
NCT07490314N/AUpdated Mar 24, 2026
Sponsor: Methodist Health System
COVID-19
United States
Evaluation of Full Versus Fractional Dose of COVID-19 Vaccine Given as a Booster for the Prevention of COVID-19 in Adults in Mongolia.Completed
NCT05265065Phase 3Updated Mar 24, 2026
Sponsor: Murdoch Childrens Research Institute
COVID-19
Mongolia
Exercise in Child HealthRecruiting
NCT05359991NAUpdated Mar 24, 2026
Sponsor: University of California, Irvine
Cystic Fibrosis · Sickle Cell Disease · SARS CoV 2 Infection
United States
Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19Completed
NCT04418206NAUpdated Mar 24, 2026
Sponsor: Centre Hospitalier Universitaire de Nice
Covid 19
France
Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant PatientsCompleted
NCT04369456NAUpdated Mar 24, 2026
Sponsor: Centre Hospitalier Universitaire de Nice
Kidney Transplant; Complications · Coronavirus Infection
France
COVID-19 Breakthrough Infection in Fully Vaccinated People and in People Who Received a Booster DoseCompleted
NCT05392075N/AUpdated Mar 24, 2026
Sponsor: Methodist Health System
COVID-19 Pneumonia · COVID-19
United States
Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19Terminated
NCT04305457Phase 2Updated Mar 23, 2026
Sponsor: Massachusetts General Hospital
Coronavirus Infections · Pneumonia, Viral · Acute Respiratory Distress Syndrome
United States
Effectiveness, Immunogenicity and Safety of the Second Booster Dose of the Vaccine Against COVID-19 in the ElderlyCompleted
NCT05283902N/AUpdated Mar 23, 2026
Sponsor: Federal University of Espirito Santo
COVID-19 · Vaccine Adverse Reaction · Vaccine-Preventable Diseases
Brazil
Investigation of Subsequent and Co-infections Associated With SARS-CoV-2 (COVID-19)Completed
NCT04561193N/AUpdated Mar 23, 2026
Sponsor: Methodist Health System
COVID-19
United States
Expanded Access Use of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Chronic Fatigue of Post-COVID ConditionAvailable
NCT07332338N/AUpdated Mar 23, 2026
Sponsor: StemCyte, Inc.
Post-COVID-19 Condition · Post-COVID Condition · Post-COVID Syndrome · Long COVID
United States
Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy PopulationCompleted
NCT04649021Phase 2Updated Mar 20, 2026
Sponsor: BioNTech SE
SARS-CoV-2
China
Bright Light Therapy for Post-COVID-19 FatigueCompleted
NCT05677932NAUpdated Mar 20, 2026
Sponsor: Chinese University of Hong Kong
Post COVID-19 Condition
Hong Kong
suPAR Michigan M2C2 Heterogeneity Validation Cohort StudyCompleted
NCT07466524N/AUpdated Mar 20, 2026
Sponsor: ViroGates A/S
COVID-19 · Severe Respiratory Distress Syndrome · Acute Respiratory Distress Syndrome
United States
NO Prevention of COVID-19 for Healthcare ProvidersTerminated
NCT04312243Phase 2Updated Mar 20, 2026
Sponsor: Massachusetts General Hospital
Coronavirus Infections · Healthcare Associated Infection
United States
Low-dose Naltrexone for Post-COVID Fatigue SyndromeCompleted
NCT05430152Phase 2Updated Mar 20, 2026
Sponsor: Luis Nacul
Post-Viral Fatigue Syndrome
Canada
Predictive Immune Biomarkers of COVID-19 Pathogenesis to Influence Therapeutic ManagementCompleted
NCT04668170N/AUpdated Mar 20, 2026
Sponsor: University Hospital, Toulouse
COVID-19
France
Improving Health Equity for COVID-19 Vaccination for At-risk Populations Using Online Social NetworksActive Not Recruiting
NCT04779827NAUpdated Mar 19, 2026
Sponsor: University of Pennsylvania
Vaccination Refusal · Covid19 · Heart Diseases
United States
MS Relapses During COVID-19 PandemicCompleted
NCT04858763N/AUpdated Mar 19, 2026
Sponsor: Nottingham University Hospitals NHS Trust
Multiple Sclerosis · Covid19 · Relapsing Remitting Multiple Sclerosis
United Kingdom

Previous page Next page